Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD.

Exp Neurol. 2001 Sep;171(1):29-45.

PMID:
11520119
2.

Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.

Lue LF, Yan SD, Stern DM, Walker DG.

Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. Review.

PMID:
15975028
3.

Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.

Lue LF, Walker DG, Rogers J.

Neurobiol Aging. 2001 Nov-Dec;22(6):945-56. Review.

PMID:
11755003
4.

Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.

Leclerc E, Sturchler E, Vetter SW, Heizmann CW.

Rev Neurosci. 2009;20(2):95-110. Review.

PMID:
19774788
5.

The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.

Schmidt AM, Sahagan B, Nelson RB, Selmer J, Rothlein R, Bell JM.

Curr Opin Investig Drugs. 2009 Jul;10(7):672-80. Review.

PMID:
19579173
6.
7.

Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease.

Verdier Y, Penke B.

Curr Protein Pept Sci. 2004 Feb;5(1):19-31. Review.

PMID:
14965318
8.

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Münch G.

Neurobiol Aging. 2011 May;32(5):763-77. doi: 10.1016/j.neurobiolaging.2009.04.016. Epub 2009 May 22. Review.

PMID:
19464758
9.

Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

Deane R, Zlokovic BV.

Curr Alzheimer Res. 2007 Apr;4(2):191-7. Review.

PMID:
17430246
10.

Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.

Kojro E, Postina R.

J Alzheimers Dis. 2009;16(4):865-78. doi: 10.3233/JAD-2009-0998. Review.

PMID:
19387119
11.

RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.

Yan SS, Chen D, Yan S, Guo L, Du H, Chen JX.

Front Biosci (Schol Ed). 2012 Jan 1;4:240-50. Review.

12.
13.

Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.

Bamberger ME, Landreth GE.

Microsc Res Tech. 2001 Jul 15;54(2):59-70. Review.

PMID:
11455613
14.

Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.

Cole GM, Ard MD.

Microsc Res Tech. 2000 Aug 15;50(4):316-24. Review.

PMID:
10936886
15.

RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?

Yan SD, Bierhaus A, Nawroth PP, Stern DM.

J Alzheimers Dis. 2009;16(4):833-43. doi: 10.3233/JAD-2009-1030. Review.

16.

Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide.

Yan SD, Roher A, Chaney M, Zlokovic B, Schmidt AM, Stern D.

Biochim Biophys Acta. 2000 Jul 26;1502(1):145-57. Review.

17.

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.

Chen X, Walker DG, Schmidt AM, Arancio O, Lue LF, Yan SD.

Curr Mol Med. 2007 Dec;7(8):735-42. Review.

PMID:
18331231
18.

Microglial activation in Alzheimer's disease.

Schlachetzki JC, Hüll M.

Curr Alzheimer Res. 2009 Dec;6(6):554-63. Review.

PMID:
19747160
19.

Microglial Aβ receptors in Alzheimer's disease.

Yu Y, Ye RD.

Cell Mol Neurobiol. 2015 Jan;35(1):71-83. doi: 10.1007/s10571-014-0101-6. Epub 2014 Aug 23. Review.

PMID:
25149075
20.

Alzheimer's disease: inside, outside, upside down.

Yan SD, Schmidt AM, Stern D.

Biochem Soc Symp. 2001;(67):15-22. Review.

PMID:
11447831

Supplemental Content

Support Center